• Please log in or register to access this feature.

Letter to the Editor

Reconciling the risk of QT interval prolongation in antidepressants

  1. A. J. Mckean,
  2. C. L. Sola,
  3. C. Galardy,
  4. S. Kung,
  5. T. W. Lineberry

Article first published online: 8 MAR 2012

DOI: 10.1002/pds.3216

Issue

Pharmacoepidemiology and Drug Safety

Pharmacoepidemiology and Drug Safety

Volume 21, Issue 3, pages 329–330, March 2012

Additional Information

How to Cite

Mckean, A. J., Sola, C. L., Galardy, C., Kung, S. and Lineberry, T. W. (2012), Reconciling the risk of QT interval prolongation in antidepressants. Pharmacoepidem. Drug Safe., 21: 329–330. doi: 10.1002/pds.3216

Author Information

  1. Mayo Clinic Department of Psychiatry and Psychology, Rochester, MN, USA

Publication History

  1. Issue published online: 8 MAR 2012
  2. Article first published online: 8 MAR 2012
  3. Manuscript Accepted: 15 NOV 2011
  4. Manuscript Received: 19 OCT 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (51K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (51K)